Purpose Of Review: To give an overview of recently published articles about the management of vasculo-Behcet's with particular emphasis on anticoagulation.
Recent Findings: Biologic agents are emerging as a potential therapeutic option in refractory vasculo-Behcet with a good safety profile. Evidence further shows that following nonpulmonary aneurysm repair, there is a reduced risk of recurrent aneurysmal formation at the operative site in patients treated with immunosuppressants in addition to their surgery, than those undergoing surgical intervention alone.
Summary: Behcet disease patients are at risk of developing multiple vascular complications including thrombosis and aneurysms. Treatment should focus on reducing inflammation; and the role of anticoagulation is still debatable.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/BOR.0000000000000458 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
SER recommendations on treatment of refractory Behçet's syndrome.
Reumatol Clin (Engl Ed)
April 2024
Servicio de Reumatología, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain.
Objective: To develop multidisciplinary recommendations based on available evidence and expert consensus for the therapeutic management of patients with refractory Behçet's syndrome (BS) (difficult to treat, severe resistant, severe relapse) to conventional treatment.
Methods: A group of experts identified clinical research questions relevant to the objective of the document. These questions were reformulated in PICO format (patient, intervention, comparison and outcome).
Recurrent myocardial infarction associated with vasculo-Behçet's disease: a case report.
Mod Rheumatol Case Rep
July 2020
Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
A 39-year-old Japanese man presented with chest oppression in February 2017. Electrocardiogram showed ST-elevation myocardial infarction (MI), and cardiac catheterisation revealed thrombotic occlusion of the right coronary artery (RCA), which was treated with thrombectomy, and he received warfarin. Three days after discharge, he complained of chest oppression again, and re-cardiac catheterisation showed thrombi occlusion of the circumflex artery (LCX) and 90% stenosis with thrombosis in the proximal site of the anterior descending artery (LAD) and RCA.
View Article and Find Full Text PDFThe Diagnosis and Management of Vasculo-Behçet's Disease.
Intern Med
January 2019
Department of Hematology and Clinical Immunology, Yokohama City University School of Medicine, Japan.
Purpose Of Review: To give an overview of recently published articles about the management of vasculo-Behcet's with particular emphasis on anticoagulation.
Recent Findings: Biologic agents are emerging as a potential therapeutic option in refractory vasculo-Behcet with a good safety profile. Evidence further shows that following nonpulmonary aneurysm repair, there is a reduced risk of recurrent aneurysmal formation at the operative site in patients treated with immunosuppressants in addition to their surgery, than those undergoing surgical intervention alone.
Aneurysm formation type of vasculo-Behcet's disease.
Heart Lung Circ
December 2007
Vascular Surgery Unit, King Hussien Medical Center, Amman, Jordan.
Purpose: To report our experience with a rare and interesting subset of Behcet's disease (BD) patients with the aneurysm formation type of angio BD.
Materials And Methods: From 1988 to 2003, five cases of the aneurysm formation type of BD were found amongst patients in Queen Alia Cardiac Center and Queen Alia Hospital Vascular Surgery Unit, Amman, Jordan. A retrospective study of the case notes and imaging was carried out.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!